2Adami S.Bisphosphonates in Prostate carcinoma.Cancer,1997,80(8):1646~1679. 被引量:1
3Hortobagyi GN,Theriault RL,Lipton A,et al.Long-term Prevention of skeletal complications of metactatic breast cancer with pamidronate:protocal 19 aredia breast cancer study group.Jclin Oncol,1998,16:2038~3044. 被引量:1
4Brunelli Mr,Einhorn TA.Medical management of osteoporosis fracture prevention.Clin Orthop,1998,348:15~21. 被引量:1
5Giuliani N,Girasole M,Pedtaizonia,et al.Alendronate stienulate mineralized uodule formationin human bone marrow culture.J Bone Miner Res,1995,10:171~174. 被引量:1
1Tyrreu CJ. Role of pamidronate in the management of bone metastases from breast cancer. Ann Oncol, 1994,5 ( Suppl 7 ) :37. 被引量:1
2Kunzmann V. Stimulation of gammadelta tcells by aminoblsphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood, 2000,96 ( 2 ) : 384 -392. 被引量:1